Home / Pharmaceuticals / Rx / Contrast Media Agents / Contrast Media / Dotarem® Gadoterate Meglumine, Preservative Free 0.5 mmol / mL Injection Single Dose Vial 15 mL67684200102
Picture of Dotarem® Gadoterate Meglumine, Preservative Free 0.5 mmol / mL Injection Single Dose Vial 15 mL67684200102

Dotarem® Gadoterate Meglumine, Preservative Free 0.5 mmol / mL Injection Single Dose Vial 15 mL67684200102

Dotarem®-Gadoterate-Meglumine,-Preservative-Free-0-5-mmol--mL-Injection-Single-Dose-Vial-15-mL67684200102

SKU #

#1155134

MPN #

67684200102

Brand

Guerbet LLC

Stock

In Stock

Quantity

100

Features

DOTAREM, VL 15ML (10/CS)

$763.61 USD

Attribute Name Attribute Value
McKesson # 1155134
Manufacturer # 67684200102
Brand Dotarem®
Manufacturer Guerbet LLC
Application Contrast Media
Container Type Single Dose Vial
Dosage Form Injection
Generic Drug Code 35139
Generic Drug Name Gadoterate Meglumine, Preservative Free
NDC Number 67684200102
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Strength 0.5 mmol / mL
Type Intravenous
UNSPSC Code 51442209
Volume 15 mL

Similar Items

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

Underarm Crutches McKesson Aluminum Frame Tall Adult 350 lbs. Weight Capacity Push Button - Adjustment

One Size Fits Most White NonSterile Not Rated 8211

In Stock

PR/1 $9.76 USD

  • DOTAREM is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (2 years of age and older) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or anormal vascularity